Humoral and cellular responses to vaccination with homologous CoronaVac or ChAdOx1 and heterologous third dose with BNT162b2

J Infect. 2022 Jun;84(6):834-872. doi: 10.1016/j.jinf.2022.02.026. Epub 2022 Feb 27.
No abstract available

Keywords: Antibodies; BNT162b2; Booster; COVID-19; ChAdOx1; CoronaVac; Interferon-gamma; Neutralizing; SARS-CoV-2; Vaccine.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antibodies, Neutralizing
  • Antibodies, Viral
  • BNT162 Vaccine*
  • COVID-19 Vaccines
  • COVID-19* / prevention & control
  • Humans
  • SARS-CoV-2
  • Vaccination

Substances

  • Antibodies, Neutralizing
  • Antibodies, Viral
  • COVID-19 Vaccines
  • BNT162 Vaccine